AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

CVS Health Corporation (CVS)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

65.75

-0.08 (-0.12%)

At close: Feb 18, 2025, 3:59 PM

65.59

-0.24%

After-hours: Feb 18, 2025, 06:21 PM EST

undefined% (undefined)

Bid	65.57
Market Cap	82.90B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	3.66
PE Ratio (ttm)	17.96
Forward PE	n/a
Analyst	Buy

Ask	65.7
Volume	7,876,934
Avg. Volume (20D)	13,590,072
Open	64.84
Previous Close	65.83
Day's Range	64.51 - 66.89
52-Week Range	43.56 - 80.75
Beta	undefined

About CVS

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment of...

[Show more]

Industry Medical - Healthcare Plans

Sector Healthcare

IPO Date Nov 20, 1996

Employees 219,000

Stock Exchange NYSE

Ticker Symbol CVS

Website https://www.cvshealth.com

Full Company Profile

Analyst Forecast

According to 17 analyst ratings, the average rating for CVS stock is "Buy." The 12-month stock price forecast is $73, which is an increase of 11.03% from the latest price.

Buy 76.47%

Hold 17.65%

Sell 0.00%

Stock Forecasts

Next Earnings Release

CVS Health Corporation is scheduled to release its earnings on Apr 30, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

5 days ago

+4.98%

CVS Health shares are trading higher after multipl... Unlock content with Pro Subscription

1 week ago

+14.95%

CVS Health shares are trading higher after the company reported Q4 earnings and revenue above estimates.

News

22 hours ago · invezz.com

Top 2 cheap stocks to buy for 2025

The US consumer price index (CPI) was up more than expected in January, raising doubts about the Federal Reserve's ability to lower interest rates further in 2025.

18 hours ago · seekingalpha.com

CVS Health: One Good Quarter Is Not Enough; Retain Sell

Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage levels. CVS' Q4 results showed a surprising EBIT margin beat, but continued ma...

21 hours ago · cnbc.com

High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models

Deshawn "DJ" Chow is one of just over 100 sickle cell patients who have undergone treatment with new gene therapies. CVS Health CEO David Joyner said private insurers and employer-sponsored health pla...

1 day ago · fool.com

Is It Too Late to Buy CVS Health Stock for the High-Yield Dividend?

After underperforming throughout 2024, shares of CVS Health (CVS -0.81%) are surging. From the end of 2024 through Feb. 14, the stock climbed 46.7% higher.

1 day ago · zacks.com

CVS Health Post-Q4 Earnings: Is the Stock Worth Buying Now?

CVS Health's adjusted EPS outlook for 2025 reflects expectations of a meaningful recovery in Medicare Advantage and continued growth in Health Services.

6 days ago · fool.com

Why CVS Stock Thrashed the Market on Thursday

For the second day in a row, CVS Health's (CVS 4.98%) stock price saw a satisfying jump on Thursday. It closed the day almost 5% higher, on the back of both lingering optimism and news of another in a...

6 days ago · benzinga.com

CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock

On Wednesday, CVS Health Corp CVS reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion.

6 days ago · cnbc.com

CVS shares are up 45% this year — here's why it may be starting to turn its business around

CVS Health could be starting to turn itself around after a dismal 2024. Its shares are up more than 45% this year, outperforming pharmacy rival Walgreens and other insurers like UnitedHealth Group and...

5 days ago · marketwatch.com

CVS wins upgrade to buy as analyst sees more upside potential than its peers

A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits businesses.

5 days ago · marketbeat.com

CVS Health: Earnings Beat Ignites Stock Rally

Shares of CVS Health Corporation NYSE: CVS experienced a jolt, rising over 15% on February 12, 2025, as the market responded to the release of its fourth-quarter 2024 earnings report. CVS Health's sto...

Load More News